Oxford Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Oxford Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,201	Closed	-$438K	–	498
2025 Q2	$438K	Buy	+20,201	New	+$477K	0.15%	233
2020 Q1	–	Sell	-259,439	Closed	-$973K	–	451
2019 Q4	$973K	Buy	259,439 +108,409	+72%	+$507K	0.03%	874
2019 Q3	$802K	Sell	151,030 -24,923	-14%	-$133K	0.02%	1051
2019 Q2	$676K	Buy	+175,953	New	+$760K	0.01%	1149
2018 Q4	–	Sell	-353,962	Closed	-$1.34M	–	1828
2018 Q3	$1.34M	Sell	353,962 -336,438	-49%	-$1.05M	0.03%	875
2018 Q2	$2.15M	Buy	690,400 +38,801	+6%	+$118K	0.04%	623
2018 Q1	$1.56M	Buy	651,599 +476,132	+271%	+$1.58M	0.03%	713
2017 Q4	$696K	Buy	175,467 +37,138	+27%	+$123K	0.02%	1079
2017 Q3	$344K	Buy	138,329 +52,161	+61%	+$143K	0.01%	1309
2017 Q2	$238K	Buy	86,168 +27,228	+46%	+$56.8K	﹤0.01%	1317
2017 Q1	$115K	Buy	58,940 +34,181	+138%	+$43.5K	﹤0.01%	1351
2016 Q4	$26K	Buy	+24,759	New	+$28.3K	﹤0.01%	753
2016 Q3	–	Sell	-180,721	Closed	-$128K	–	779
2016 Q2	$128K	Buy	180,721 +6,140	+4%	+$4.95K	﹤0.01%	723
2016 Q1	$204K	Buy	+174,581	New	+$271K	0.01%	710

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oxford Asset Management's CPRX Position: Q3 2025 in Review

Oxford Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2025, closing a stake of 20,201 shares — an estimated $438K sold.

Oxford Asset Management first reported a position in CPRX in Q1 2016 and held it in 14 quarters. The position peaked at $2.15M in Q2 2018. 360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

Oxford Asset Management reported no remaining Catalyst Pharmaceutical position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 20,201 Catalyst Pharmaceutical shares in Q3 2025, an estimated $438K.
Oxford Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2016 and held it in 14 quarters.
Oxford Asset Management's Catalyst Pharmaceutical position peaked at $2.15M in Q2 2018.
360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.